Researchers still found 'excellent' survival rates for both primary, secondary disease
This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Experts say while it can help in advanced disease, that doesn't mean it works at all stages
Thu Dec 13, 2012 10:15 AM
Oh that's very sad to know that, even after sucessful trial and spending so much, there is no authenticate source who can say the trial is right or wrong.
If this is the case why does FDI approve this drug. Its directly hamperring the life of so many affected people, considering the amout this drug costs to the people.
We care about your feedback. Let us know how we can improve your CancerCompass experience.